Eagle Hero Management Limited - Net Worth and Insider Trading

Eagle Hero Management Limited Net Worth

The estimated net worth of Eagle Hero Management Limited is at least $731 Million dollars as of 2024-11-08. Eagle Hero Management Limited is the 2101 Beneficial owner of Keymed Biosciences Inc and owns about 16,359,069 shares of Keymed Biosciences Inc (HKSE:02162) stock worth over $731 Million. Details can be seen in Eagle Hero Management Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eagle Hero Management Limited has not made any transactions after 2022-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Eagle Hero Management Limited

Eagle Hero Management Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eagle Hero Management Limited owns 1 companies in total, including Keymed Biosciences Inc (HKSE:02162) .

Click here to see the complete history of Eagle Hero Management Limited’s form 4 insider trades.

Insider Ownership Summary of Eagle Hero Management Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02162	Keymed Biosciences Inc	2022-05-12	2101 Beneficial owner

Eagle Hero Management Limited Latest Holdings Summary

Eagle Hero Management Limited currently owns a total of 1 stock. Eagle Hero Management Limited owns 16,359,069 shares of Keymed Biosciences Inc (HKSE:02162) as of May 12, 2022, with a value of $731 Million.

Latest Holdings of Eagle Hero Management Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02162	Keymed Biosciences Inc	2022-05-12	16,359,069	44.70	731,250,384

Holding Weightings of Eagle Hero Management Limited

Eagle Hero Management Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Eagle Hero Management Limited has made a total of 1 transactions in Keymed Biosciences Inc (HKSE:02162) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Keymed Biosciences Inc is the sale of 1,617,084 shares on May 12, 2022, which brought Eagle Hero Management Limited around $0.

Insider Trading History of Eagle Hero Management Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eagle Hero Management Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eagle Hero Management Limited Ownership Network

Ownership Network List of Eagle Hero Management Limited

No Data

Ownership Network Relation of Eagle Hero Management Limited

Eagle Hero Management Limited Owned Company Details

What does Keymed Biosciences Inc do?

Who are the key executives at Keymed Biosciences Inc?

Eagle Hero Management Limited is the 2101 Beneficial owner of Keymed Biosciences Inc. Other key executives at Keymed Biosciences Inc include 2201 Interest of corporation controlled by you Chen Bo , 2301 Trustee Trident Trust Company (hk) Limited , and 2101 Beneficial owner Moonshot Holdings Limited .

Keymed Biosciences Inc (HKSE:02162) Insider Trades Summary

Over the past 18 months, Eagle Hero Management Limited made no insider transaction in Keymed Biosciences Inc (HKSE:02162). Other recent insider transactions involving Keymed Biosciences Inc (HKSE:02162) include a net sale of 87,500 shares made by Chen Bo ,

In summary, during the past 3 months, insiders sold 0 shares of Keymed Biosciences Inc (HKSE:02162) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,500 shares of Keymed Biosciences Inc (HKSE:02162) were sold and 27,000 shares were bought by its insiders, resulting in a net sale of 87,500 shares.

Keymed Biosciences Inc (HKSE:02162)'s detailed insider trading history can be found in Insider Trading Tracker table.

Keymed Biosciences Inc Insider Transactions

No Available Data

Eagle Hero Management Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Eagle Hero Management Limited. Currently GuruFocus does not have mailing address information for Eagle Hero Management Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.